Related Experiment Videos
Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large
Weiyi Chen1, Jane Houldsworth, Adam B Olshen
1Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Blood
|December 1, 2005
Summary
Array comparative genomic hybridization identified small DNA copy number changes linked to diffuse large B-cell lymphoma (DLBCL) patient survival. Specific chromosomal losses and gains predict poor or good outcomes, aiding in DLBCL prognosis.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Diffuse large B-cell lymphoma (DLBCL) has a high mortality rate, necessitating improved prognostic markers.
- Understanding genetic alterations in DLBCL is crucial for identifying therapeutic targets and improving patient outcomes.
Purpose of the Study:
- To identify DNA copy number changes associated with patient outcome in DLBCL using high-resolution array comparative genomic hybridization (array-CGH).
- To correlate specific genomic regions with overall survival and DLBCL subtypes.
Main Methods:
- Array-CGH was performed on 64 newly diagnosed DLBCL patient specimens treated with anthracycline-based chemotherapy.
- Analysis identified commonly gained/lost regions and correlated copy number changes with survival data and cell-of-origin subtypes.
Main Results:
- Fifty-five commonly gained/lost regions were identified across the cohort.
- Nine minimal regions significantly correlated with overall survival, with six being 10 Mbp or smaller.
- Loss of chromosomes 2 and 16 predicted poor survival, while loss of chromosome 1 predicted good survival.
- Gain of chromosome 12 was associated with the germinal center B-cell-like DLBCL subtype.
Conclusions:
- Array-CGH identified small genomic regions associated with DLBCL patient outcome.
- These findings may reveal critical target genes for understanding DLBCL clinical behavior and developing new therapies.